EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence and machine learning for precision warfarin dosing: a comprehensive narrative review

Mohammadsadra Shamohammadi, Mohammad Ali Nazari, Seyedeh Mohadese Mosavi Mirkalaie, Bahram Fadaee Dowlat, Donya Hoseini, Armaghan Abbasi Garavand, Sara Javid, Kaveh Hosseini

European Journal of Clinical Pharmacology · 2026-03 · 82 (3)

DOI: 10.1007/s00228-026-03997-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 06.02.2026. Verfasst von Mohammadsadra Shamohammadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Warfarin, Machine Learning, Artificial Intelligence, Anticoagulants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Warfarin remains one of the most widely used anticoagulants; however, its narrow therapeutic index means that even small dosing deviations can result in thromboembolic or bleeding events, necessitating close monitoring and strict control of the international normalized ratio (INR). MAIN BODY: Although traditional warfarin dosing algorithms incorporating CYP2C9 and VKORC1 genotypes improve upon fixed-dose regimens, they explain less than 50% of dose variability and perform inconsistently across populations. These limitations underscore the need for more adaptive and precise dosing methodologies. Artificial intelligence (AI) and machine learning (ML) have been recognized as powerful approaches to advance warfarin dose individualization. This narrative review synthesizes literature on machine learning approaches to warfarin dosing, including support vector regression, neural networks, ensemble models, and reinforcement learning, with a focus on predictive performance and clinical relevance. Overall, the literature indicates that ML-based warfarin dosing models may improve prediction of the therapeutic warfarin dose and regulation of INR levels compared with traditional clinical and pharmacogenetic interventions. However, many published models are constrained by small sample sizes and limited external validation, reducing generalizability. Methodological heterogeneity and inconsistent reporting further underscore persistent gaps in the evidence base. CONCLUSION: AI and ML approaches have shown potential advantages over clinical and pharmacogenetic dosing methods for warfarin, with some studies reporting lower prediction errors and improved therapeutic INR control. However, further studies are needed to draw definitive conclusions about their comparative effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinMachine LearningArtificial IntelligenceAnticoagulantsHumansInternational Normalized RatioPrecision MedicineReinforcement Machine LearningPharmacogeneticsPredictive Learning Models

Stichwörter der Autor:innen

AnticoagulationINRMachine learningModel-informed precision dosingPharmacogenomicsPrecision dosingReinforcement learningVitamin k antagonistsWarfarin

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran.
  • Cardiovascular Disease Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. kaveh_hosseini130@yahoo.com.
  • Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. kaveh_hosseini130@yahoo.com.

Zitieren

APA

Shamohammadi, M., Nazari, M. A., Mirkalaie, S. M. M., Dowlat, B. F., Hoseini, D., Garavand, A. A., Javid, S., & Hosseini, K. (2026). Artificial intelligence and machine learning for precision warfarin dosing: a comprehensive narrative review. European Journal of Clinical Pharmacology, 82(3). https://doi.org/10.1007/s00228-026-03997-w

Vancouver

Shamohammadi M, Nazari MA, Mirkalaie SMM, Dowlat BF, Hoseini D, Garavand AA, et al. Artificial intelligence and machine learning for precision warfarin dosing: a comprehensive narrative review. European Journal of Clinical Pharmacology. 2026;82(3). doi:10.1007/s00228-026-03997-w

BibTeX
@article{Shamohammadi2026,
  author = {Shamohammadi, Mohammadsadra and Nazari, Mohammad Ali and Mirkalaie, Seyedeh Mohadese Mosavi and Dowlat, Bahram Fadaee and Hoseini, Donya and Garavand, Armaghan Abbasi and Javid, Sara and Hosseini, Kaveh},
  title = {Artificial intelligence and machine learning for precision warfarin dosing: a comprehensive narrative review},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {3},
  doi = {10.1007/s00228-026-03997-w}
}
Kostenlos starten →